Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIQ

Healthcare Biotechnology

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > Buyer beware!

<< Previous

Bullboard Posts

Next >>

Comment by biggerron Apr 25, 2021 7:25pm

393 Views

Post# 33064380

RE:Buyer beware!

They've been saying since last November that if they get enough money they'll be launching generic Seroquel XR®, generic Pristiq® and generic Effexor XR® and now with the PP they could have the money. These brand names were big money makers and this will inrease the revenue significantly IMHO, right now revenue is zero

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly